Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hodgkin Disease × Watchful Waiting × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 2 Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 14 Carcinoma, Non-Small-Cell Lung 9 Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4 Colonic Neoplasms 4 Papillomavirus Infections 3 Neuroblastoma 3 Lung Neoplasms 3 Brain Neoplasms 3 Anus Neoplasms 3 Uterine Cervical Dysplasia 2 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Squamous Intraepithelial Lesions 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Lymphoma, Large B-Cell, Diffuse 2 Liver Neoplasms 2 HIV Infections 2 Gallbladder Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Bile Duct Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Ureteral Neoplasms 1 Thyroid Nodule 1

Interventions

Cyclophosphamide 172 Etoposide 97 fludarabine phosphate 95 Peripheral Blood Stem Cell Transplantation 82 Filgrastim 77 Mycophenolic Acid 73 Doxorubicin 72 Melphalan 69 Whole-Body Irradiation 68 Radiotherapy 65 Brentuximab Vedotin 64 fludarabine 60 Tacrolimus 60 Busulfan 59 Cyclosporine 54 Vinblastine 53 Rituximab 52 Dacarbazine 46 Bleomycin 45 Granulocyte Colony-Stimulating Factor 44 Gemcitabine 42 Vincristine 40 Prednisone 40 Antilymphocyte Serum 40 Cytarabine 39 Methotrexate 35 Carmustine 33 Nivolumab 32 pembrolizumab 31 Sirolimus 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01088750 2023-12-13

EuroNetLP1

Martin-Luther-Universität Halle-Wittenberg

Phase 4 Completed

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡